<p>隨着全球市場在利率調整和混合經濟信號的複雜環境中航行，亞洲股市面臨着自身的一系列挑戰，日本經歷了顯著的加息，而中國的增長指標則顯示出停滯的跡象。在這種環境下，識別被低估的股票對尋求相對當前市場估值潛在價值的投資者尤其具有吸引力。</p>
<h3>基於現金流的亞洲十大被低估股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>當前價格</strong></td>
<td><strong>公允價值（估計）</strong></td>
<td><strong>折扣（估計）</strong></td>
</tr>
<tr>
<td>西安諾瓦星雲科技（SZSE:301589）</td>
<td>CN¥154.88</td>
<td>CN¥302.77</td>
<td>48.8%</td>
</tr>
<tr>
<td>三一重工國際控股（SEHK:631）</td>
<td>HK$8.50</td>
<td>HK$16.36</td>
<td>48.1%</td>
</tr>
<tr>
<td>匯量科技（SEHK:1860）</td>
<td>HK$15.40</td>
<td>HK$30.69</td>
<td>49.8%</td>
</tr>
<tr>
<td>Kuraray（TSE:3405）</td>
<td>¥1600.00</td>
<td>¥3167.00</td>
<td>49.5%</td>
</tr>
<tr>
<td>H.U.集團控股（TSE:4544）</td>
<td>¥3364.00</td>
<td>¥6592.59</td>
<td>49%</td>
</tr>
<tr>
<td>FIT Hon Teng（SEHK:6088）</td>
<td>HK$5.70</td>
<td>HK$11.22</td>
<td>49.2%</td>
</tr>
<tr>
<td>第一三共（TSE:4568）</td>
<td>¥3332.00</td>
<td>¥6544.37</td>
<td>49.1%</td>
</tr>
<tr>
<td>CURVES HOLDINGS（TSE:7085）</td>
<td>¥795.00</td>
<td>¥1573.75</td>
<td>49.5%</td>
</tr>
<tr>
<td>Cowell e Holdings（SEHK:1415）</td>
<td>HK$27.92</td>
<td>HK$55.44</td>
<td>49.6%</td>
</tr>
<tr>
<td>北京超強科技（SHSE:688411）</td>
<td>CN¥259.90</td>
<td>CN¥515.12</td>
<td>49.5%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們基於現金流的 273 只被低估亞洲股票的完整列表。</p>
<p>讓我們深入探討一些篩選出的優質選擇。</p>
<h2>微創醫療（SEHK:853）</h2>
<p><strong>概述：</strong> 微創醫療科技有限公司，市值為 HK$198.8 億，專注於在中國、歐洲、中東和非洲、日本及其他國際市場創新、製造和銷售醫療設備。</p>
<p><strong>運營：</strong> 公司的收入主要來自其骨科設備業務（$249.94 百萬）、心臟節律管理業務（$221.36 百萬）、心血管設備業務（不包括 CRM）、外科機器人設備和心臟瓣膜業務（$161.90 百萬）、血管內和外周血管設備業務（$158.41 百萬）、神經血管設備業務（$102.90 百萬）、結構性心臟病業務（$51.25 百萬）和外科機器人設備業務（$46.54 百萬）。</p>
<p><strong>公允價值折扣估計：</strong> 11.2%</p>
<p>微創醫療的交易價格為 HK$10.39，低於其估計的公允價值 HK$11.7，表明基於折現現金流分析的潛在低估。儘管預測的股本回報率較低，僅為 8.8%，但預計其收益將在三年內顯著增長並實現盈利，超過市場平均增長率。最近的治理變更旨在增強決策過程，可能在長期內加強公司的戰略方向和財務管理能力。</p>
<ul>
<li>我們最近的增長報告提供了微創醫療業務前景的良好預測。</li>
<li>在這裏深入瞭解微創醫療的具體情況，查看我們的全面財務健康報告。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/01e4ab24-131a-49b3-be55-470430002299/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1706" height="760" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/01e4ab24-131a-49b3-be55-470430002299/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SEHK:853 截至 2025 年 12 月的折現現金流</p>
<h2>北京超強科技（SHSE:688411）</h2>
<p><strong>概述：</strong> 北京超強科技有限公司專注於在中國設計、開發、集成和運營儲能電站，市值為 CN¥468.1 億。</p>
<p><strong>運營：</strong> 收入細分（單位：百萬 CN¥）：</p>
<p><strong>公允價值折扣估計：</strong> 49.5%</p>
<p>北京超強科技的當前交易價格為 CN¥259.9，相較於其估計的公允價值 CN¥515.12，基於折現現金流分析顯著低估。預計公司的收入和收益將大幅增長，超過中國市場的整體增長率。儘管最近股價波動，最新的財報顯示強勁表現，銷售額達到 CN¥79.1 億，淨收入在 2025 年 9 月同比翻倍至 CN¥6.226 億。</p>
<ul>
<li>我們編制的增長報告表明，北京超強科技的未來前景可能向好。</li>
<li>在這裏深入分析完整的健康報告，以更深入瞭解北京超強科技。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3bfd9198-7ed0-45a8-8819-04c19d1aa84b/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1706" height="760" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3bfd9198-7ed0-45a8-8819-04c19d1aa84b/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SHSE:688411 截至 2025 年 12 月的折現現金流</p>
<h2>Chenbro Micom（TWSE:8210）</h2>
<p><strong>概述：</strong> Chenbro Micom 有限公司專注於全球計算機外設和系統的研發、設計、製造、加工和貿易，市值為 NT$1161.1 億。</p>
<p><strong>運營：</strong> 公司的計算機外設收入為 NT$191.3 億。</p>
<p><strong>公允價值折扣估計：</strong> 25.1%</p>
<p>Chenbro Micom 的交易價格為 NT$955，相較於其公允價值估計 NT$1275.28 被低估。公司財務健康狀況良好，第三季度銷售額從去年的 NT$42.7 億上升至 NT$56.6 億，淨收入從 NT$6.4377 億增加至 NT$9.9332 億。預計未來三年收益將顯著增長，超過台灣市場的增長率，儘管最近股價波動。</p>
<ul>
<li>我們的 Chenbro Micom 增長報告中的分析暗示未來財務表現強勁。</li>
<li>點擊這裏瞭解 Chenbro Micom 的細微差別，查看我們的詳細財務健康報告。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/20c14362-c610-4fac-bc81-76b0778aa369/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1706" height="760" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/20c14362-c610-4fac-bc81-76b0778aa369/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TWSE:8210 截至 2025 年 12 月的折現現金流</p>
<h2>關鍵要點</h2>
<ul>
<li>深入瞭解我們在這裏識別的 273 只基於現金流的被低估亞洲股票。</li>
<li>你已經投資這些股票了嗎？通過設置 Simply Wall St 的投資組合，隨時掌握每一個動態，讓投資者像你一樣保持信息靈通和積極主動。</li>
<li>使用 Simply Wall St 提升你的投資組合，這是尋求全球市場覆蓋的投資者的終極應用程序。</li>
</ul>
<h2>準備好探索其他投資風格了嗎？</h2>
<ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>通過提供可靠收入來源的穩健分紅股票來多元化你的投資組合，以應對潛在的市場波動。</li>
<li>用顯示強勁增長潛力的公司來充實你的投資組合，這些公司得到了分析師和管理層的樂觀展望支持。</li>
</ul>
<p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議，也不構成買賣任何股票的推薦，並未考慮你的目標或財務狀況。</strong> 我們旨在為你提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
<p>移動基礎設施用於國防和災難</p>
<p>下一波機器人技術不是人形的。它是完全自主的塔，在 30 分鐘內提供 5G、ISR 和雷達，覆蓋任何地方。</p>
<p>在下一輪合同之前獲取投資者簡報</p>
<p>代表 CiTech 贊助</p>

諾瓦星雲

三一重工

匯量科技

<p>這篇文章強調了被低估的亞洲股票，其中一些股票的交易價格低於估計的公允價值 49.5%。文章指出了西安諾瓦星雲科技、三一重工和匯量科技等頂級股票。微創醫療和北京超強科技被認為具有潛在的低估和增長前景。分析表明，這些股票可能基於折現現金流分析提供投資機會</p>

<p>As global markets navigate a complex landscape marked by interest rate adjustments and mixed economic signals, Asia's stock markets have faced their own set of challenges, with Japan experiencing significant rate hikes and China's growth indicators showing signs of stagnation. In this environment, identifying undervalued stocks can be particularly appealing to investors looking for opportunities that may offer potential value relative to current market valuations.</p>
<div class="lb-trans"><p>隨着全球市場在利率調整和混合經濟信號的複雜環境中航行，亞洲股市面臨着自身的一系列挑戰，日本經歷了顯著的加息，而中國的增長指標則顯示出停滯的跡象。在這種環境下，識別被低估的股票對尋求相對當前市場估值潛在價值的投資者尤其具有吸引力。</p>
</div><h3>Top 10 Undervalued Stocks Based On Cash Flows In Asia</h3>
<div class="lb-trans"><h3>基於現金流的亞洲十大被低估股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Current Price</strong></td>
<td><strong>Fair Value (Est)</strong></td>
<td><strong>Discount (Est)</strong></td>
</tr>
<tr>
<td>Xi'an NovaStar Tech (SZSE:301589)</td>
<td>CN¥154.88</td>
<td>CN¥302.77</td>
<td>48.8%</td>
</tr>
<tr>
<td>Sany Heavy Equipment International Holdings (SEHK:631)</td>
<td>HK$8.50</td>
<td>HK$16.36</td>
<td>48.1%</td>
</tr>
<tr>
<td>Mobvista (SEHK:1860)</td>
<td>HK$15.40</td>
<td>HK$30.69</td>
<td>49.8%</td>
</tr>
<tr>
<td>Kuraray (TSE:3405)</td>
<td>¥1600.00</td>
<td>¥3167.00</td>
<td>49.5%</td>
</tr>
<tr>
<td>H.U. Group Holdings (TSE:4544)</td>
<td>¥3364.00</td>
<td>¥6592.59</td>
<td>49%</td>
</tr>
<tr>
<td>FIT Hon Teng (SEHK:6088)</td>
<td>HK$5.70</td>
<td>HK$11.22</td>
<td>49.2%</td>
</tr>
<tr>
<td>Daiichi Sankyo Company (TSE:4568)</td>
<td>¥3332.00</td>
<td>¥6544.37</td>
<td>49.1%</td>
</tr>
<tr>
<td>CURVES HOLDINGS (TSE:7085)</td>
<td>¥795.00</td>
<td>¥1573.75</td>
<td>49.5%</td>
</tr>
<tr>
<td>Cowell e Holdings (SEHK:1415)</td>
<td>HK$27.92</td>
<td>HK$55.44</td>
<td>49.6%</td>
</tr>
<tr>
<td>Beijing HyperStrong Technology (SHSE:688411)</td>
<td>CN¥259.90</td>
<td>CN¥515.12</td>
<td>49.5%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>當前價格</strong></td>
<td><strong>公允價值（估計）</strong></td>
<td><strong>折扣（估計）</strong></td>
</tr>
<tr>
<td>西安諾瓦星雲科技（SZSE:301589）</td>
<td>CN¥154.88</td>
<td>CN¥302.77</td>
<td>48.8%</td>
</tr>
<tr>
<td>三一重工國際控股（SEHK:631）</td>
<td>HK$8.50</td>
<td>HK$16.36</td>
<td>48.1%</td>
</tr>
<tr>
<td>匯量科技（SEHK:1860）</td>
<td>HK$15.40</td>
<td>HK$30.69</td>
<td>49.8%</td>
</tr>
<tr>
<td>Kuraray（TSE:3405）</td>
<td>¥1600.00</td>
<td>¥3167.00</td>
<td>49.5%</td>
</tr>
<tr>
<td>H.U.集團控股（TSE:4544）</td>
<td>¥3364.00</td>
<td>¥6592.59</td>
<td>49%</td>
</tr>
<tr>
<td>FIT Hon Teng（SEHK:6088）</td>
<td>HK$5.70</td>
<td>HK$11.22</td>
<td>49.2%</td>
</tr>
<tr>
<td>第一三共（TSE:4568）</td>
<td>¥3332.00</td>
<td>¥6544.37</td>
<td>49.1%</td>
</tr>
<tr>
<td>CURVES HOLDINGS（TSE:7085）</td>
<td>¥795.00</td>
<td>¥1573.75</td>
<td>49.5%</td>
</tr>
<tr>
<td>Cowell e Holdings（SEHK:1415）</td>
<td>HK$27.92</td>
<td>HK$55.44</td>
<td>49.6%</td>
</tr>
<tr>
<td>北京超強科技（SHSE:688411）</td>
<td>CN¥259.90</td>
<td>CN¥515.12</td>
<td>49.5%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 273 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們基於現金流的 273 只被低估亞洲股票的完整列表。</p>
</div><p>Let's dive into some prime choices out of the screener.</p>
<div class="lb-trans"><p>讓我們深入探討一些篩選出的優質選擇。</p>
</div><h2>MicroPort Scientific (SEHK:853)</h2>
<div class="lb-trans"><h2>微創醫療（SEHK:853）</h2>
</div><p><strong>Overview:</strong> MicroPort Scientific Corporation, with a market cap of HK$19.88 billion, is involved in innovating, manufacturing, and marketing medical devices across the People's Republic of China, Europe, the Middle East and Africa, Japan, and other international markets.</p>
<div class="lb-trans"><p><strong>概述：</strong> 微創醫療科技有限公司，市值為 HK$198.8 億，專注於在中國、歐洲、中東和非洲、日本及其他國際市場創新、製造和銷售醫療設備。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its Orthopedics Devices Business ($249.94 million), Cardiac Rhythm Management Business ($221.36 million), Cardiovascular Devices Business excluding CRM, Surgical Robot Device, and Heart Valve Business ($161.90 million), Endovascular and Peripheral Vascular Devices Business ($158.41 million), Neurovascular Devices Business ($102.90 million), Structural Heart Disease Business ($51.25 million), and Surgical Robot Devices Business ($46.54 million).</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自其骨科設備業務（$249.94 百萬）、心臟節律管理業務（$221.36 百萬）、心血管設備業務（不包括 CRM）、外科機器人設備和心臟瓣膜業務（$161.90 百萬）、血管內和外周血管設備業務（$158.41 百萬）、神經血管設備業務（$102.90 百萬）、結構性心臟病業務（$51.25 百萬）和外科機器人設備業務（$46.54 百萬）。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 11.2%</p>
<div class="lb-trans"><p><strong>公允價值折扣估計：</strong> 11.2%</p>
</div><p>MicroPort Scientific is trading at HK$10.39, below its estimated fair value of HK$11.7, indicating potential undervaluation based on discounted cash flow analysis. Despite a low forecasted return on equity of 8.8%, its earnings are expected to grow significantly and become profitable within three years, surpassing average market growth rates. Recent governance changes aim to enhance decision-making processes, potentially strengthening the company's strategic direction and financial management capabilities in the long term.</p>
<div class="lb-trans"><p>微創醫療的交易價格為 HK$10.39，低於其估計的公允價值 HK$11.7，表明基於折現現金流分析的潛在低估。儘管預測的股本回報率較低，僅為 8.8%，但預計其收益將在三年內顯著增長並實現盈利，超過市場平均增長率。最近的治理變更旨在增強決策過程，可能在長期內加強公司的戰略方向和財務管理能力。</p>
</div><ul>
<li>Insights from our recent growth report point to a promising forecast for MicroPort Scientific's business outlook.</li>
<li>Dive into the specifics of MicroPort Scientific here with our thorough financial health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我們最近的增長報告提供了微創醫療業務前景的良好預測。</li>
<li>在這裏深入瞭解微創醫療的具體情況，查看我們的全面財務健康報告。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/01e4ab24-131a-49b3-be55-470430002299/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/01e4ab24-131a-49b3-be55-470430002299/chart/dcf?theme=light"/></p>
<p>SEHK:853 Discounted Cash Flow as at Dec 2025</p>
<div class="lb-trans"><p>SEHK:853 截至 2025 年 12 月的折現現金流</p>
</div><h2>Beijing HyperStrong Technology (SHSE:688411)</h2>
<div class="lb-trans"><h2>北京超強科技（SHSE:688411）</h2>
</div><p><strong>Overview:</strong> Beijing HyperStrong Technology Co., Ltd. specializes in the design, development, integration, and operation of energy storage power stations in China, with a market cap of CN¥46.81 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 北京超強科技有限公司專注於在中國設計、開發、集成和運營儲能電站，市值為 CN¥468.1 億。</p>
</div><p><strong>Operations:</strong> Revenue Segments (in millions of CN¥):</p>
<div class="lb-trans"><p><strong>運營：</strong> 收入細分（單位：百萬 CN¥）：</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 49.5%</p>
<div class="lb-trans"><p><strong>公允價值折扣估計：</strong> 49.5%</p>
</div><p>Beijing HyperStrong Technology, with a current trading price of CN¥259.9, is significantly undervalued compared to its estimated fair value of CN¥515.12 based on discounted cash flow analysis. The company's revenue and earnings are forecast to grow substantially, outpacing the broader Chinese market's growth rates. Despite recent share price volatility, recent earnings reports show strong performance with sales reaching CN¥7.91 billion and net income doubling year-over-year to CN¥622.6 million by September 2025.</p>
<div class="lb-trans"><p>北京超強科技的當前交易價格為 CN¥259.9，相較於其估計的公允價值 CN¥515.12，基於折現現金流分析顯著低估。預計公司的收入和收益將大幅增長，超過中國市場的整體增長率。儘管最近股價波動，最新的財報顯示強勁表現，銷售額達到 CN¥79.1 億，淨收入在 2025 年 9 月同比翻倍至 CN¥6.226 億。</p>
</div><ul>
<li>The growth report we've compiled suggests that Beijing HyperStrong Technology's future prospects could be on the up.</li>
<li>Delve into the full analysis health report here for a deeper understanding of Beijing HyperStrong Technology.</li>
</ul>
<div class="lb-trans"><ul>
<li>我們編制的增長報告表明，北京超強科技的未來前景可能向好。</li>
<li>在這裏深入分析完整的健康報告，以更深入瞭解北京超強科技。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3bfd9198-7ed0-45a8-8819-04c19d1aa84b/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/3bfd9198-7ed0-45a8-8819-04c19d1aa84b/chart/dcf?theme=light"/></p>
<p>SHSE:688411 Discounted Cash Flow as at Dec 2025</p>
<div class="lb-trans"><p>SHSE:688411 截至 2025 年 12 月的折現現金流</p>
</div><h2>Chenbro Micom (TWSE:8210)</h2>
<div class="lb-trans"><h2>Chenbro Micom（TWSE:8210）</h2>
</div><p><strong>Overview:</strong> Chenbro Micom Co., Ltd. is involved in the R&amp;D, design, manufacture, processing, and trading of computer peripherals and systems globally, with a market cap of NT$116.11 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Chenbro Micom 有限公司專注於全球計算機外設和系統的研發、設計、製造、加工和貿易，市值為 NT$1161.1 億。</p>
</div><p><strong>Operations:</strong> The company's revenue from computer peripherals amounts to NT$19.13 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的計算機外設收入為 NT$191.3 億。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 25.1%</p>
<div class="lb-trans"><p><strong>公允價值折扣估計：</strong> 25.1%</p>
</div><p>Chenbro Micom, trading at NT$955, is undervalued compared to its fair value estimate of NT$1,275.28. The company shows strong financial health with third-quarter sales rising to NT$5.66 billion from NT$4.27 billion year-over-year and net income increasing to NT$993.32 million from NT$643.77 million. Earnings are projected to grow significantly over the next three years, surpassing Taiwan's market growth rates despite recent share price volatility.</p>
<div class="lb-trans"><p>Chenbro Micom 的交易價格為 NT$955，相較於其公允價值估計 NT$1275.28 被低估。公司財務健康狀況良好，第三季度銷售額從去年的 NT$42.7 億上升至 NT$56.6 億，淨收入從 NT$6.4377 億增加至 NT$9.9332 億。預計未來三年收益將顯著增長，超過台灣市場的增長率，儘管最近股價波動。</p>
</div><ul>
<li>The analysis detailed in our Chenbro Micom growth report hints at robust future financial performance.</li>
<li>Click here to discover the nuances of Chenbro Micom with our detailed financial health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我們的 Chenbro Micom 增長報告中的分析暗示未來財務表現強勁。</li>
<li>點擊這裏瞭解 Chenbro Micom 的細微差別，查看我們的詳細財務健康報告。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/20c14362-c610-4fac-bc81-76b0778aa369/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/20c14362-c610-4fac-bc81-76b0778aa369/chart/dcf?theme=light"/></p>
<p>TWSE:8210 Discounted Cash Flow as at Dec 2025</p>
<div class="lb-trans"><p>TWSE:8210 截至 2025 年 12 月的折現現金流</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>關鍵要點</h2>
</div><ul>
<li>Dive into all 273 of the Undervalued Asian Stocks Based On Cash Flows we have identified here.</li>
<li>Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.</li>
<li>Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.</li>
</ul>
<div class="lb-trans"><ul>
<li>深入瞭解我們在這裏識別的 273 只基於現金流的被低估亞洲股票。</li>
<li>你已經投資這些股票了嗎？通過設置 Simply Wall St 的投資組合，隨時掌握每一個動態，讓投資者像你一樣保持信息靈通和積極主動。</li>
<li>使用 Simply Wall St 提升你的投資組合，這是尋求全球市場覆蓋的投資者的終極應用程序。</li>
</ul>
</div><h2>Ready To Venture Into Other Investment Styles?</h2>
<div class="lb-trans"><h2>準備好探索其他投資風格了嗎？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未獲得顯著分析師關注的高表現小型公司。</li>
<li>通過提供可靠收入來源的穩健分紅股票來多元化你的投資組合，以應對潛在的市場波動。</li>
<li>用顯示強勁增長潛力的公司來充實你的投資組合，這些公司得到了分析師和管理層的樂觀展望支持。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.</strong> We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議，也不構成買賣任何股票的推薦，並未考慮你的目標或財務狀況。</strong> 我們旨在為你提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>移動基礎設施用於國防和災難</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波機器人技術不是人形的。它是完全自主的塔，在 30 分鐘內提供 5G、ISR 和雷達，覆蓋任何地方。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一輪合同之前獲取投資者簡報</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>代表 CiTech 贊助</p>
</div>

三隻亞洲股票的交易價格估計低於其公允價值，幅度最高可達 49.5%